Research


July 24, 2020

Grant Gives UAMS Physician-Scientist Access to Gene Analysis Software

Susan Van Dusen

Dr. Analiz Rodriguez

New grant funding will assist UAMS physician-scientist Analiz Rodriguez, M.D., Ph.D., in identifying more effective therapies for patients whose cancer has spread to their brain.


July 23, 2020

Fenghuang “Frank” Zhan, M.D., Ph.D., Awarded Nearly $3.14 Million to Further Myeloma Research

Linda Haymes

Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer.

LITTLE ROCK — Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer. One grant from the U.S. Department of Defense provides $1.4…


July 21, 2020

National Cancer Database at UAMS Becomes U.S. Storehouse for COVID-19 Images

David Robinson

A Chest Radiograph (left) and Computed Tomography (CT) image (right) of the same COVID-19 patient taken one day apart. These UAMS images, now publicly available in the national Cancer Imaging Archive, show COVID-19 lung infection similar to pneumonia. Medical experts refer to the appearance as ground glass opacities, a haziness overlying the lung that is common with COVID-19 patients.

LITTLE ROCK — A national database for patient cancer images at UAMS will become the storage site for COVID-19 clinical images from across the United States and around the globe, including chest x-rays and CT scans of the body. This week, UAMS also became the first research institution to contribute de-identified images of COVID-19 to…


June 25, 2020

UAMS Cancer Institute Joins KIYATEC Clinical Study of Test to Predict Pre-Treatment, Patient-Specific Response to Ovarian Cancer Drugs

Susan Van Dusen

Michael Birrer, MD, PhD

KIYATEC, Inc. today announced that the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has joined the growing roster of institutions participating in its 3D-PREDICT clinical study to validate the company’s test as a patient-specific predictor of response to recommended drug therapies for patients with ovarian cancer.


June 22, 2020

UAMS Part of International Effort to Build AI Platform for Cancer Research

David Robinson

Fred Prior, Ph.D., has a leading role in international effort to apply artificial intelligence to cancer research.

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) will have a key role in a major international effort using artificial intelligence (AI) to teach computers at local research centers how to recognize cancer. UAMS has received a four-year grant of $894,074 as part of EuCanImage, a nearly $9 million cancer research project…


June 3, 2020

Findings on DNA Damage Repair Published by UAMS Cancer Researcher

Susan Van Dusen

Leung research team

A research team led by cancer researcher Justin Leung, Ph.D., at the University of Arkansas for Medical Sciences (UAMS) has uncovered the role of the protein RNF168 in DNA damage repair and shown how mutations of the protein affect people with a rare genetic condition.


May 6, 2020

UAMS Radiation Oncologist Awarded $1.86 Million National Cancer Institute Grant

Susan Van Dusen

Fen Xia, M.D., Ph.D.

A five-year grant of more than $1.86 million from the National Cancer Institute (NCI) to the University of Arkansas for Medical Sciences (UAMS) will fund research aimed at reducing long-term neurological damage caused by a common cancer treatment regimen.


February 7, 2020

Proteomics Symposium Draws Leaders from Across the Country

Susan Van Dusen

proteomics workshop

To conduct biomedical research, scientists must be able to identify, analyze and compare proteins in biological samples. This complex process requires facilities – known as proteomics cores – that house the specialized equipment and highly trained staff required for such a task.


February 4, 2020

Research at UAMS Shows Potential to Reduce Chemo-related Heart Damage

Susan Van Dusen

Valentina Todorova, PhD

A team led by UAMS cancer researcher Valentina Todorova, Ph.D., has demonstrated the potential to prevent chemotherapy-induced heart damage without reducing the treatment’s effectiveness.


December 11, 2019

Laura Hutchins, M.D., Honored as Dean’s Distinguished Scholar

Susan Van Dusen

Hutchins and Westfall at lecture

When a young Laura Hutchins’ mom encouraged her to get a part-time job, she found one in a clinical lab not far from her parents’ dairy farm in northeastern Mississippi. It didn’t take long for the teenager to realize that lab work was more stimulating than cleaning barns. It also was quickly apparent to her…



Next page